For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Documentation

Peptide modifications explained

Many research peptides are not a plain chain of the twenty standard amino acids. Terminal caps, non-natural residues, ring closures and attached groups all change the expected mass, and many change how the peptide behaves in the lab.

Published 18 November 2026

Why modifications matter when you check a batch

A modification changes the molecular formula, so it changes the mass you should expect in a mass spectrum. It can also change net charge, hydrophobicity, HPLC retention time and solubility. When you compare a COA with your order, check that the sequence notation includes every modification you expect, and that the measured mass matches a calculation that includes them. See Peptide purity: HPLC and mass spectrometry explained.

Common modifications at a glance

Mass changes below are monoisotopic and are relative to the unmodified peptide.

ModificationTypical notationMass changeMain effects
C-terminal amidation…-NH2 (e.g. …-Gly-NH2)−0.984 DaRemoves the C-terminal negative charge
N-terminal acetylationAc-… (e.g. Ac-Ala-…)+42.011 DaRemoves the N-terminal positive charge; slightly more hydrophobic
D-amino acidD-Ala, or lower-case one-letter code (a)NoneCan change conformation and resistance to proteases in vitro; HPLC retention may shift
Disulfide bridge"Disulfide bridge: Cys2–Cys7", or a connecting line in a structure drawing−2.016 Da per bridgeConstrains conformation; free thiols no longer present
Head-to-tail cyclisation (amide bond)cyclo(…)−18.011 DaBoth terminal charges removed; conformation constrained
N-terminal pyroglutamatepGlu-… or Pyr-…−17.027 Da from Gln; −18.011 Da from GluN-terminal charge removed; can also form unintentionally from N-terminal Gln
PhosphorylationpSer, pThr, pTyr, or Ser(PO3H2)+79.966 Da per groupAdds negative charge; often lowers HPLC retention
PEGylationPEG chain named by length or average mass (e.g. PEG4, PEG 2 kDa)+44.026 Da per ethylene glycol unitMore hydrophilic; larger hydrodynamic size
Palmitoylation (C16 lipid)Pal-, or Lys(Pal)+238.230 DaMuch more hydrophobic; prone to aggregation and adsorption
Biotin labelBiotin-…, or Lys(Biotin)+226.078 DaEnables streptavidin-based capture and detection
Carboxyfluorescein (FAM) label5-FAM-…, 5(6)-FAM-…+358.048 DaFluorescent; light-sensitive
Fluorescein isothiocyanate (FITC) labelFITC-…+389.036 DaFluorescent; light-sensitive

Terminal modifications

C-terminal amidation replaces the C-terminal carboxyl group with a carboxamide. Many naturally occurring peptides are amidated, and synthetic versions are made on resins that release the amide directly. The mass difference from the free acid is under 1 Da, so a low-resolution spectrum may not distinguish the two clearly; the notation on the COA and a correctly calculated mass are the best checks.

N-terminal acetylation caps the N-terminal amine. Together with amidation, it is often used to make a short synthetic peptide resemble the same segment within a longer protein, where the ends are not charged. Both caps change the net charge, which affects solubility and the choice of solvent. See Dissolving peptides for in-vitro assays.

D-amino acids and other non-standard residues

A D-amino acid has the same formula as its L-form, so the mass spectrum cannot confirm it. Confirming stereochemistry needs a method that separates enantiomers, such as chiral chromatography after hydrolysis. Other non-standard residues, such as norleucine, ornithine or aminohexanoic acid (Ahx, often used as a spacer, +113.084 Da), are usually written with three-letter or bracketed abbreviations; check the supplier's key if an abbreviation is unfamiliar.

Disulfide bridges and cyclisation

A disulfide bridge forms when two cysteine thiols are oxidised, losing two hydrogen atoms (−2.016 Da). Peptides with more than one bridge can form different pairings with the same mass, so the documentation should state which cysteines are linked and how this was confirmed. A sample of a disulfide-bridged peptide that shows a mass about 2 Da higher than expected per bridge may contain the reduced form.

Head-to-tail cyclisation forms an amide bond between the N- and C-termini, with the loss of one water molecule (−18.011 Da). Side chain-to-side chain lactam bridges, for example between lysine and aspartic or glutamic acid side chains, involve the same loss of water.

PEGylation and lipidation

Polyethylene glycol (PEG) chains come in two forms. Discrete PEGs, with a defined number of ethylene glycol units, add a single defined mass. Conventional polymeric PEGs are polydisperse: the mass spectrum shows a distribution of peaks spaced 44 Da apart rather than one peak, and the documentation should quote an average mass.

Lipidation attaches a fatty acid, usually to the N-terminus or to a lysine side chain. Lipidated peptides are markedly more hydrophobic: they elute much later in reversed-phase HPLC, often need an organic co-solvent to dissolve, and can stick to plastic and glass surfaces.

Labels

Biotin and fluorescent labels are usually attached at the N-terminus or to a lysine side chain, often through a spacer such as Ahx to reduce interference between the label and the peptide. An N-terminal FITC label attached directly to the peptide can be lost during acidic cleavage from the synthesis resin, which is one reason a spacer is commonly used. Fluorescent peptides should be stored and handled protected from light.

How modifications appear on a spec sheet

  • Sequence line: modifications written into the sequence, such as Ac-, -NH2, Lys(Biotin) or cyclo(…).
  • Bridge or cyclisation statement: which residues are linked.
  • Molecular formula and molecular weight: these should include every modification. A quick check is to compare them with the value calculated for the unmodified sequence plus the mass changes above.
  • MS result: the observed mass should match the modified, not the unmodified, peptide.

Related: How to read a peptide Certificate of Analysis and Common impurities in synthetic peptides.

Further reading

Sources and further reading

  • Unimod: protein modifications for mass spectrometry (unimod.org), for monoisotopic mass changes of common modifications.
  • Chan WC, White PD (eds). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press; 2000.
  • United States Pharmacopeia, General Chapter <1503> Quality Attributes of Synthetic Peptide Drug Substances.

Frequently asked questions

How much does C-terminal amidation change the mass?

-0.984 Da relative to the free acid, which a low-resolution spectrum may not resolve; the COA notation and a correctly calculated mass are the best checks.

What does N-terminal acetylation change?

+42.011 Da, and it removes the N-terminal positive charge.

Does a D-amino acid change the mass?

No. It has the same mass but can change conformation, protease resistance and HPLC retention.

Why do modifications matter when checking a batch?

They change the formula, so the expected mass, and they can change charge, hydrophobicity, retention time and solubility. The measured mass should match a calculation that includes every modification.